Gröger Victoria, Cynis Holger
Department of Drug Design and Target Validation, Fraunhofer Institute for Cell Therapy and Immunology, Halle, Germany.
Front Microbiol. 2018 Feb 20;9:265. doi: 10.3389/fmicb.2018.00265. eCollection 2018.
Human endogenous retroviruses (HERVs) are remnants of retroviral germ line infections of human ancestors and make up ~8% of the human genome. Under physiological conditions, these elements are frequently inactive or non-functional due to deactivating mutations and epigenetic control. However, they can be reactivated under certain pathological conditions and produce viral transcripts and proteins. Several disorders, like multiple sclerosis or amyotrophic lateral sclerosis are associated with increased HERV expression. Although their detailed contribution to individual diseases has yet to be elucidated, an increasing number of studies and suggest HERVs as potent modulators of the immune system. They are able to affect the transcription of other immune-related genes, interact with pattern recognition receptors, and influence the positive and negative selection of developing thymocytes. Interestingly, HERV envelope proteins can both stimulate and suppress immune responses based on different mechanisms. In the light of HERV proteins becoming an emerging drug target for autoimmune-related disorders and cancer, we will provide an overview on recent findings of the complex interactions between HERVs and the human immune system with a focus on autoimmunity.
人类内源性逆转录病毒(HERVs)是人类祖先逆转录病毒种系感染的残余物,约占人类基因组的8%。在生理条件下,由于失活突变和表观遗传控制,这些元件通常处于无活性或无功能状态。然而,它们在某些病理条件下可被重新激活,并产生病毒转录本和蛋白质。多种疾病,如多发性硬化症或肌萎缩侧索硬化症,都与HERV表达增加有关。尽管它们对个体疾病的确切作用尚待阐明,但越来越多的研究表明HERVs是免疫系统的有效调节因子。它们能够影响其他免疫相关基因的转录,与模式识别受体相互作用,并影响发育中胸腺细胞的阳性和阴性选择。有趣的是,HERV包膜蛋白可基于不同机制刺激和抑制免疫反应。鉴于HERV蛋白正成为自身免疫相关疾病和癌症的新兴药物靶点,我们将概述HERVs与人类免疫系统之间复杂相互作用的最新研究结果,重点关注自身免疫。